The US Oncology Network

Congrats to the 26 physicians from Virginia Cancer Specialists, P.C. who were recently named 2024 Top Doctors by Washingtonian Magazine! We're proud to have you in The Network. Find out more below. #TopDoctors2024 #HealthcareHeroes #HealthcareExcellence

WATCH: Gary Simmons DO, MSHA of Virginia Oncology Associates discusses CAR T-cell therapy: what it is, how it differs from other treatments, and how clinical trials may affect the future of this therapy. https://lnkd.in/eT3JXn4K #CARTcell #Immunotherapy #CancerTreatment

READ: In this Targeted Oncology article, Dr. John Burke of Rocky Mountain Cancer Centers discusses CDK4/6 inhibitors and whether or not they would be effective and cost-efficient for patients with breast cancer. Find out more here: https://lnkd.in/eSraYy2R #BreastCancerResearch #BreastCancerTreatment #MedicalResearch

WATCH: In this interview, Erika Hamilton, MD of the Sarah Cannon Research Institute discusses breast cancer myths, as well as the importance of considering clinical trials as a first treatment option for breast cancer. Reasons for this include: -- Positive outcomes from initial clinical trials that can help move new breast cancer treatments forward -- Access to cutting-edge treatments that aren't available anywhere else -- Close monitoring of patients, which can allow for more personalized care -- Good alternatives for patients who aren't responding to standard treatments -- Potential availability of treatment and some related medical care for free https://lnkd.in/etk5dENf #ClinicalTrials #BreastCancerTreatment #BreastCancer

As cancer treatment continues to evolve, so do the challenges associated with delivering high-quality care and ensuring positive patient experiences. In this environment, The Network is dedicated to actively empowering practices to deliver outstanding care to patients. Find out more about how we can help here: https://lnkd.in/gX9TwnNv #PatientCenteredCare #VBC #ClinicalServices

For the ninth consecutive year, the Centers for Medicare & Medicaid Services (CMS) has named McKesson a Qualified Clinical Data Registry (QCDR) approved to participate in the Merit-based Incentive Payment System (MIPS). We’re proud that seven of the nine supported QCDR measures were developed in collaboration with physicians in The Network. Especially noteworthy and new for 2025 is the first patient-reported outcomes measure available through MIPS, assessing outcomes associated with addressing health-related social needs (HRSNs). While other quality measures screen for HRSNs, McKesson’s is the first to examine whether issues are resolved after being identified. To learn more about how we are advocating for quality measures that are truly impactful to patients and oncology care, read our press release: https://lnkd.in/gKVH2Bcy #Oncology #MIPS #QCDR #PatientCare

In 2024, we had 62 new physicians join existing practices in The Network. We're glad to have you with us delivering excellence in cancer care each day. And in 2025, we’ve already welcomed: From Comprehensive Cancer Centers of Nevada: 🩺 Dr. Tooba Mohammad, Breast Surgeon 🩺 Dr. Ammar Yousif, Hematologist/Oncologist From NEXT Oncology: 🩺 Dr. Jennifer Segar, Hematologist/Oncologist

READ: A good write-up from Minnesota Oncology on biomarkers, including what they are, how physicians test for them, and where they fit into lung cancer treatment. Currently, the FDA has approved targeted therapy for eight biomarkers, making testing a good option for certain cancer patients. Find out more below. #Biomarkers #LungCancerTreatment #CancerResearch

🔍 Leading the Way in Oncology Quality Programs   As CMS continues to implement MIPS Value Pathways (MVPs), oncology practices face a new set of challenges. Erin Crum, Sr. Director of Quality Strategy and Innovation at The US Oncology Network, shares how The Network is helping practices navigate this transition with unparalleled expertise and innovative tools.   With deep knowledge of value-based care, specialty-specific EHR integration, and quality measurement, The Network empowers practices to reduce administrative burdens, optimize patient care, and thrive in this evolving landscape.   Learn how The Network is leading the charge in transforming oncology care: https://lnkd.in/gPtiN8xQ   #OncologyLeadership #ValueBasedCare #MIPSValuePathways

READ: Virginia Cancer Specialists, P.C. has started an exciting new radiopharmaceutical clinical trial that could offer a wider range of treatment for cancer patients. Radiopharmaceuticals allow for more precise targeting of cancer cells that minimizes damage to surrounding healthy tissue. Find out more here: https://lnkd.in/esMmFRWe Alex Spira, MD, PhD, FACP, FASCO #CancerTreatment #Radiopharmaceuticals #ClinicalTrials